The E&M Co., Ltd. (KOSDAQ:089230)
2,395.00
+245.00 (11.40%)
At close: Jun 10, 2026
The E&M Revenue
The E&M had revenue of 6.20B KRW in the quarter ending March 31, 2026, with 97.77% growth. This brings the company's revenue in the last twelve months to 15.40B, down -18.51% year-over-year. In the year 2025, The E&M had annual revenue of 12.34B, down -44.40%.
Revenue (ttm)
15.40B
Revenue Growth
-18.51%
P/S Ratio
5.65
Revenue / Employee
211.01M
Employees
73
Market Cap
86.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.34B | -9.86B | -44.40% |
| Dec 31, 2024 | 22.20B | -9.51B | -29.98% |
| Dec 31, 2023 | 31.70B | -14.90B | -31.97% |
| Dec 31, 2022 | 46.60B | -7.28B | -13.51% |
| Dec 31, 2021 | 53.88B | -4.74B | -8.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| THINKWARE | 513.59B |
| CoAsia | 392.99B |
| Theragen Etex | 272.93B |
| SEOWONINTECH. | 177.17B |
| DK Life Science | 128.38B |
| Osang Healthcare Co.,Ltd | 119.38B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 108.89B |
| Model Solution | 76.50B |